Clinical Medicine


JIM 2025; 2 (3): e996
DOI: 10.61012_20258_996

Ten-year experience of newborn screening for glutaric aciduria type 1 in northeast Italy: successes, challenges and unexpected findings

JIM 2025; 2 (3): e998
DOI: 10.61012_20258_998

Exploring neuropathic pain in Fabry Disease: a review of pathogenesis, diagnostic pitfalls and management starting from clinical cases

JIM 2025; 2 (3): e1003
DOI: 10.61012_20258_1003

Potential applications of digital health technologies in adults with inherited metabolic disorders

JIM 2025; 2 (Suppl 1): e958
DOI: 10.61012_20256_958

Adult phenylketonuria: transition management and follow-up

JIM 2025; 2 (2): e924
DOI: 10.61012_20255_924

A diagnostic x-ray in a newborn with skeletal abnormalities: a rare case of mucolipidosis type 2

JIM 2025; 2 (2): e922
DOI: 10.61012_20255_922

Primary lipid myopathies: a narrative review

JIM 2025; 2 (1): e712
DOI: 10.61012_20252_712

Adolescent perceptions of healthcare services for inherited metabolic disorders and genetic diseases: insights from a survey in a pediatric hospital

JIM 2025; 2 (1): e709
DOI: 10.61012_20252_709

Genotype and phenotype of subjects with Tangier disease developing cardiovascular disease

JIM 2025; 2 (1): e707
DOI: 10.61012_20252_707

Changes in the care of patients with lysosomal storage diseases in the post-COVID-19 era

JIM 2025; 2 (1): e685
DOI: 10.61012_20252_685

Author Correction – Newborn screening, diagnosis, and management of inherited metabolic disorders: status and progress of the southern mediterranean countries

JIM 2024; 1 (4): e634
DOI: 10.61012_202411_634

Acid sphingomyelinase deficiency: a complex and rare disorder that needs clinicians’ awareness